Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03505554Phase 2Completed
A Study of Oral Lorlatinib in Patients With Relapsed ALK Positive Lymphoma
Anaplastic Large Cell Lymphoma, ALK-Positive
PrincipalinvestigatorStart date: 2019-09-28
NCT02638467Phase 2Completed
Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy
BCR-ABL PositiveChronicLeukemia+1 more
PrincipalinvestigatorStart date: 2015-11-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03505554Phase 2PrincipalInvestigator

A Study of Oral Lorlatinib in Patients With Relapsed ALK Positive Lymphoma

Anaplastic Large Cell Lymphoma, ALK-Positive
Completed
NCT02638467Phase 2PrincipalInvestigator

Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy

BCR-ABL PositiveChronicLeukemia+1 more
Completed

All 2 trials loaded